FI965154A - Lääkkeen paksusuoleen kuljettava koostumus - Google Patents
Lääkkeen paksusuoleen kuljettava koostumus Download PDFInfo
- Publication number
- FI965154A FI965154A FI965154A FI965154A FI965154A FI 965154 A FI965154 A FI 965154A FI 965154 A FI965154 A FI 965154A FI 965154 A FI965154 A FI 965154A FI 965154 A FI965154 A FI 965154A
- Authority
- FI
- Finland
- Prior art keywords
- drug
- colon
- composition
- drugs
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9412394 | 1994-06-21 | ||
GB9412394A GB9412394D0 (en) | 1994-06-21 | 1994-06-21 | Colonic drug delivery composition |
GB9501458 | 1995-06-21 | ||
PCT/GB1995/001458 WO1995035100A1 (en) | 1994-06-21 | 1995-06-21 | Colonic drug delivery composition |
Publications (3)
Publication Number | Publication Date |
---|---|
FI965154A0 FI965154A0 (fi) | 1996-12-20 |
FI965154A true FI965154A (fi) | 1997-02-20 |
FI118626B FI118626B (fi) | 2008-01-31 |
Family
ID=10757052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI965154A FI118626B (fi) | 1994-06-21 | 1996-12-20 | Kooloniin annettava lääkekoostumus |
Country Status (14)
Country | Link |
---|---|
US (2) | US6228396B1 (fi) |
EP (1) | EP0810857B1 (fi) |
JP (1) | JP2986217B2 (fi) |
AT (1) | ATE204751T1 (fi) |
AU (1) | AU688060B2 (fi) |
CA (1) | CA2193481C (fi) |
DE (1) | DE69522475T2 (fi) |
DK (1) | DK0810857T3 (fi) |
ES (1) | ES2162922T3 (fi) |
FI (1) | FI118626B (fi) |
GB (1) | GB9412394D0 (fi) |
NO (1) | NO315686B1 (fi) |
PT (1) | PT810857E (fi) |
WO (1) | WO1995035100A1 (fi) |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5686106A (en) * | 1995-05-17 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form for colonic delivery |
GB9620709D0 (en) * | 1996-10-04 | 1996-11-20 | Danbiosyst Uk | Colonic delivery of weak acid drugs |
KR20000053327A (ko) * | 1996-11-15 | 2000-08-25 | 데이비드 엠 모이어 | 결장내 운반에 사용되는 약학적 제형 |
US5891474A (en) * | 1997-01-29 | 1999-04-06 | Poli Industria Chimica, S.P.A. | Time-specific controlled release dosage formulations and method of preparing same |
DE19732903A1 (de) | 1997-07-30 | 1999-02-04 | Falk Pharma Gmbh | Pellet-Formulierung zur Behandlung des Intestinaltraktes |
US8765177B2 (en) * | 1997-09-12 | 2014-07-01 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
US7153845B2 (en) * | 1998-08-25 | 2006-12-26 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
GB9800912D0 (en) * | 1998-01-17 | 1998-03-11 | Danbiosyst Uk | New composition |
AU735084B2 (en) * | 1998-02-09 | 2001-06-28 | Joel Bolonick | Treatment of chronic inflammatory disorders of the gastrointestinal tract |
US7022683B1 (en) | 1998-05-13 | 2006-04-04 | Carrington Laboratories, Inc. | Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation |
JP5068401B2 (ja) * | 1998-09-28 | 2012-11-07 | カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップ | Hpmcカプセルを使用する腸及び結腸への送達 |
DE19923817A1 (de) * | 1999-05-18 | 2000-11-23 | Roland Bodmeier | Kapsel mit kontrollierter Wirkstofffreisetzung |
EP1184038B1 (en) * | 1999-06-09 | 2005-12-28 | Mochida Pharmaceutical Co., Ltd. | System for release in lower digestive tract |
US6340473B1 (en) * | 1999-07-07 | 2002-01-22 | R.P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
IT1318625B1 (it) * | 2000-07-14 | 2003-08-27 | Roberto Valducci | Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente. |
WO2002040039A2 (en) | 2000-11-20 | 2002-05-23 | Dow Global Technologies Inc. | In vivo use of water absorbent polymers |
US7494669B2 (en) * | 2001-02-28 | 2009-02-24 | Carrington Laboratories, Inc. | Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
US6777000B2 (en) * | 2001-02-28 | 2004-08-17 | Carrington Laboratories, Inc. | In-situ gel formation of pectin |
ES2376739T3 (es) | 2001-03-27 | 2012-03-16 | Galectin Therapeutics Inc. | Administración conjunta de un polisacárido con un agente quimioterapéutico para el tratamiento del cáncer |
US6645946B1 (en) | 2001-03-27 | 2003-11-11 | Pro-Pharmaceuticals, Inc. | Delivery of a therapeutic agent in a formulation for reduced toxicity |
EP1539208A2 (en) * | 2002-06-28 | 2005-06-15 | Nastech Pharmaceutical Company Inc. | Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
US11116782B2 (en) | 2002-10-15 | 2021-09-14 | Celgene Corporation | Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine |
US8404716B2 (en) | 2002-10-15 | 2013-03-26 | Celgene Corporation | Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine |
US8404717B2 (en) * | 2002-10-15 | 2013-03-26 | Celgene Corporation | Methods of treating myelodysplastic syndromes using lenalidomide |
TWI355276B (en) * | 2003-01-14 | 2012-01-01 | Akira Tsuji | Gastrointestinal absorption enhancer mediated by p |
EP1620732A2 (en) * | 2003-04-30 | 2006-02-01 | Nastech Pharmaceutical Company Inc. | Claudins' underexpression as markers of tumor metastasis |
WO2005007110A2 (en) * | 2003-07-11 | 2005-01-27 | Pro-Pharmaceuticals, Inc. | Compositions and methods for hydrophobic drug delivery |
US7825106B2 (en) | 2003-09-03 | 2010-11-02 | Agi Therapeutics Ltd. | Modified release formulations and methods of treating inflammatory bowel disease |
US7737133B2 (en) | 2003-09-03 | 2010-06-15 | Agi Therapeutics Ltd. | Formulations and methods of treating inflammatory bowel disease |
US20050053664A1 (en) * | 2003-09-08 | 2005-03-10 | Eliezer Zomer | Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
US20050129679A1 (en) * | 2003-12-15 | 2005-06-16 | Nastech Pharmaceutical Company Inc. | Method for opening tight junctions |
WO2005079314A2 (en) * | 2004-02-13 | 2005-09-01 | Pro-Pharmaceuticals, Inc. | Compositions and methods used to treat acne and candida |
US20040224019A1 (en) * | 2004-03-03 | 2004-11-11 | Adi Shefer | Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs |
WO2006017417A2 (en) * | 2004-08-02 | 2006-02-16 | Pro-Pharmaceuticals, Inc. | Compositions and methods for the enhancement of chemotherapy with microbial cytotoxins |
GB0421121D0 (en) | 2004-09-22 | 2004-10-27 | Natrocell Technologies Ltd | Composite rodenticide |
GB0517957D0 (en) | 2005-09-03 | 2005-10-12 | Morvus Technology Ltd | Method of combating infection |
GB0526552D0 (en) | 2005-12-29 | 2006-02-08 | Morvus Technology Ltd | New use |
US7964215B1 (en) | 2006-01-24 | 2011-06-21 | Emet Pharmaceuticals, LLC | Delayed release dosage form |
GB0607534D0 (en) * | 2006-04-13 | 2006-05-24 | Univ London Pharmacy | Colonic drug delivery formulation |
WO2008028193A2 (en) * | 2006-09-01 | 2008-03-06 | Pharmion Corporation | Colon-targeted oral formulations of cytidine analogs |
US9227011B2 (en) * | 2006-09-29 | 2016-01-05 | MEDIMETRICS Personalized Drug Delivery B.V. | Miniaturized threshold sensor |
GB2442202A (en) | 2006-09-30 | 2008-04-02 | Morvus Technology Ltd | Vermin poison |
EP2066309B1 (en) | 2007-04-04 | 2012-08-29 | Sigmoid Pharma Limited | An oral pharmaceutical composition |
US20090036414A1 (en) * | 2007-08-02 | 2009-02-05 | Mutual Pharmaceutical Company, Inc. | Mesalamine Formulations |
WO2009126742A2 (en) * | 2008-04-08 | 2009-10-15 | Appian Labs, Llc | Enzyme mediated delivery system |
GB0808537D0 (en) | 2008-05-12 | 2008-06-18 | Archimedes Dev Ltd | Compositions |
WO2009139888A1 (en) | 2008-05-15 | 2009-11-19 | Celgene Corporation | Oral formulations of cytidine analogs and methods of use thereof |
CA2743491C (en) | 2008-11-11 | 2016-10-11 | Zelton Dave Sharp | Inhibition of mammalian target of rapamycin |
US9283211B1 (en) | 2009-11-11 | 2016-03-15 | Rapamycin Holdings, Llc | Oral rapamycin preparation and use for stomatitis |
US20170079962A1 (en) | 2009-11-11 | 2017-03-23 | Rapamycin Holdings, Llc | Oral Rapamycin Preparation and Use for Stomatitus |
US11759441B2 (en) | 2011-01-07 | 2023-09-19 | Anji Pharmaceuticals Inc. | Biguanide compositions and methods of treating metabolic disorders |
US11974971B2 (en) | 2011-01-07 | 2024-05-07 | Anji Pharmaceuticals Inc. | Compositions and methods for treating metabolic disorders |
US20120276056A1 (en) * | 2011-04-26 | 2012-11-01 | Wieslaw Janusz Bochenek | Method for Use of Biologic Agents Including Live or Dormant Forms of Bacteria and other organisms in Treating Infections, Inflammation and Other Diseases of Distal Small Intestine and Large Intestine |
KR20200137035A (ko) | 2012-01-06 | 2020-12-08 | 앤지 파마 유에스 엘엘씨 | 바이구아나이드 조성물 및 대사 장애를 치료하는 방법 |
BR112014024159A2 (pt) * | 2012-03-29 | 2017-06-20 | Therabiome Llc | Formulações de vacina oral específicas do local gastrintestinal , ativas no íleo e apêndice. |
US20140066837A1 (en) | 2012-07-26 | 2014-03-06 | Ronald L. Moy | Skin care compositions and methods |
US20160030401A1 (en) | 2013-03-13 | 2016-02-04 | The Board Of Regents Of The University Of Texas System | Use of mtor inhibitors for prevention of intestinal polyp growth and cancer |
US9907755B2 (en) | 2013-03-14 | 2018-03-06 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
KR20150140649A (ko) | 2013-04-05 | 2015-12-16 | 폴리켐 에스.에이. | 과민성 대장 증후군을 치료하기 위한 피도티모드의 사용 |
BR112015025296A2 (pt) * | 2013-04-05 | 2017-07-18 | Polichem Sa | uso de pidotimod para o tratamento de doença inflamatória intestinal |
US9700544B2 (en) | 2013-12-31 | 2017-07-11 | Neal K Vail | Oral rapamycin nanoparticle preparations |
CA3206208A1 (en) | 2013-12-31 | 2015-07-09 | Rapamycin Holdings, Llc | Oral rapamycin nanoparticle preparations and use |
DK3107568T3 (da) * | 2014-02-20 | 2024-06-03 | Vaxart Inc | Formuleringer til indgivelse til tyndtarmen |
SI3182996T1 (sl) | 2014-08-22 | 2023-04-28 | Celgene Corporation | Postopki zdravljenja multiplega mieloma z imunomodulatornimi spojinami v kombinaciji s protitelesi |
CN118045170A (zh) | 2015-06-12 | 2024-05-17 | 瓦克萨特公司 | 用于rsv和诺如病毒抗原的小肠递送的制剂 |
PE20181295A1 (es) | 2015-09-01 | 2018-08-07 | First Wave Bio Inc | Metodos y composiciones para tratar afecciones asociadas a una respuesta inflamatoria anomala |
US10588864B2 (en) | 2016-03-11 | 2020-03-17 | Gateway Pharmaceuticals LLC | Pharmaceutical compositions for colon-specific delivery |
CN106380636B (zh) * | 2016-08-30 | 2019-05-14 | 华南理工大学 | 一种壳聚糖接枝的抗消化淀粉载体材料及其制备方法和应用 |
CN108201531A (zh) * | 2016-12-19 | 2018-06-26 | 湖南尔康湘药制药有限公司 | 高溶解性磺苄西林钠结肠靶向淀粉胶囊及其制备方法 |
EP3612196A4 (en) | 2017-04-18 | 2021-01-13 | Actorius Innovations and Research Pvt. Ltd. | POLYMER-BASED FORMULATION FOR THE RELEASE OF DRUGS AND BIOACTIVE PRODUCTS AT SPECIFIC GIT SITES |
WO2019211419A1 (en) * | 2018-05-03 | 2019-11-07 | M.W. Encap Limited | Dosage forms for delivery of medicines to the lower gastrointestinal tract |
US20230102999A1 (en) | 2020-01-10 | 2023-03-30 | First Wave Bio, Inc. | Deuterated niclosamide |
US20230190684A1 (en) | 2020-03-16 | 2023-06-22 | First Wave Bio, Inc. | Methods of treating covid-19 with a niclosamide compound |
US10980756B1 (en) | 2020-03-16 | 2021-04-20 | First Wave Bio, Inc. | Methods of treatment |
EP4327806A4 (en) | 2021-04-20 | 2024-10-23 | Jiangsu Hengrui Pharmaceuticals Co Ltd | CAPSULE FOR SPECIFIC MEDICATION DELIVERY AND MANUFACTURING PROCESS THEREFOR |
US11896719B2 (en) | 2022-01-24 | 2024-02-13 | Calliditas Therapeutics Ab | Pharmaceutical compositions |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA825384B (en) * | 1981-07-31 | 1983-05-25 | Tillott J B Ltd | Orally administrable pharmaceutical compositions |
US4738724A (en) * | 1983-11-04 | 1988-04-19 | Warner-Lambert Company | Method for forming pharmaceutical capsules from starch compositions |
US4673438A (en) * | 1984-02-13 | 1987-06-16 | Warner-Lambert Company | Polymer composition for injection molding |
US4663308A (en) | 1984-07-18 | 1987-05-05 | Medical College Of Ohio | Method of use of polymers containing cross-linked azo bonds for releasing therapeutic agents into the lower gastrointestinal tract |
US4627851A (en) | 1984-10-26 | 1986-12-09 | Alza Corporation | Colonic-therapeutic delivery system |
US4668517A (en) | 1985-04-04 | 1987-05-26 | Norwich Eaton Pharmaceuticals, Inc. | Furazolidone dosage form |
IL77186A0 (en) * | 1985-11-29 | 1986-04-29 | Touitou Elka | Pharmaceutical insulin composition |
US4945080A (en) * | 1987-05-26 | 1990-07-31 | Eli Lilly And Company | Dirithromycin metabolite |
EP0313845A1 (en) * | 1987-09-29 | 1989-05-03 | Warner-Lambert Company | Stabilization of enteric coated dosage form |
DE3869337D1 (de) * | 1987-11-20 | 1992-04-23 | Greither Peter | Kapsel und verfahren zu ihrer herstellung. |
DE8715583U1 (de) * | 1987-11-24 | 1988-01-28 | Greither, Peter, Kirchberg | Kapsel |
DE3812799A1 (de) | 1988-04-16 | 1989-10-26 | Sanol Arznei Schwarz Gmbh | Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung |
GB8812490D0 (en) | 1988-05-26 | 1988-06-29 | Agricultural & Food Res | Delayed release formulations |
US5342624A (en) * | 1989-02-16 | 1994-08-30 | British Technology Group Ltd. | Dispensing device |
CA2032475C (en) | 1989-05-11 | 1997-12-30 | Heiji Ikushima | Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines |
US5032405A (en) * | 1989-09-27 | 1991-07-16 | Warner-Lambert Company | Oral pharmaceutical composition for acid sensitive proteinaceous agents |
BE1003677A3 (nl) * | 1990-01-29 | 1992-05-19 | Schacht Etienne | Werkwijze voor het bereiden van azobevattende polymeren en het gebruik ervan als geneesmiddelafgiftesystemen. |
IL98087A (en) * | 1990-05-04 | 1996-11-14 | Perio Prod Ltd | Preparation for dispensing drugs in the colon |
WO1992018147A1 (en) * | 1991-04-19 | 1992-10-29 | Affinity Biotech, Inc. | Convertible microemulsion formulations |
WO1993009785A1 (en) * | 1991-11-22 | 1993-05-27 | Procter & Gamble Pharmaceuticals, Inc. | Risedronate delayed-release compositions |
DE4236025A1 (de) | 1992-10-24 | 1994-04-28 | Merck Patent Gmbh | Orale Arzneiformen |
US5656290A (en) | 1993-02-26 | 1997-08-12 | The Procter & Gamble Company | Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
US5686105A (en) | 1993-10-19 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
BR9405836A (pt) | 1993-02-26 | 1996-01-16 | Procter & Gamble | Forma de dosagem de bisacodil |
US5651983A (en) * | 1993-02-26 | 1997-07-29 | The Procter & Gamble Company | Bisacodyl dosage form for colonic delivery |
DE69425453T2 (de) | 1993-04-23 | 2001-04-12 | Novartis Ag, Basel | Wirkstoffabgabevorrichtung mit gesteuerter Freigabe |
DE4329503A1 (de) | 1993-09-01 | 1995-03-02 | Galenik Labor Freiburg Gmbh | Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa |
AU7961094A (en) | 1993-10-19 | 1995-05-08 | Procter & Gamble Company, The | Picosulphate dosage form |
US5514663A (en) | 1993-10-19 | 1996-05-07 | The Procter & Gamble Company | Senna dosage form |
JPH09510182A (ja) * | 1993-11-17 | 1997-10-14 | エルディーエス・テクノロジーズ・インコーポレーテッド | カプセル封入されたドラッグデリバリー用透明液 |
US5482718A (en) | 1994-03-23 | 1996-01-09 | Hoffmann-La Roche Inc. | Colon-targeted delivery system |
US5686106A (en) | 1995-05-17 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form for colonic delivery |
US5891474A (en) * | 1997-01-29 | 1999-04-06 | Poli Industria Chimica, S.P.A. | Time-specific controlled release dosage formulations and method of preparing same |
-
1994
- 1994-06-21 GB GB9412394A patent/GB9412394D0/en active Pending
-
1995
- 1995-06-21 PT PT95922632T patent/PT810857E/pt unknown
- 1995-06-21 WO PCT/GB1995/001458 patent/WO1995035100A1/en active IP Right Grant
- 1995-06-21 ES ES95922632T patent/ES2162922T3/es not_active Expired - Lifetime
- 1995-06-21 AT AT95922632T patent/ATE204751T1/de active
- 1995-06-21 DE DE69522475T patent/DE69522475T2/de not_active Expired - Lifetime
- 1995-06-21 AU AU27460/95A patent/AU688060B2/en not_active Expired
- 1995-06-21 CA CA002193481A patent/CA2193481C/en not_active Expired - Lifetime
- 1995-06-21 US US08/765,347 patent/US6228396B1/en not_active Expired - Lifetime
- 1995-06-21 JP JP8501842A patent/JP2986217B2/ja not_active Expired - Lifetime
- 1995-06-21 EP EP95922632A patent/EP0810857B1/en not_active Expired - Lifetime
- 1995-06-21 DK DK95922632T patent/DK0810857T3/da active
-
1996
- 1996-12-18 NO NO19965436A patent/NO315686B1/no not_active IP Right Cessation
- 1996-12-20 FI FI965154A patent/FI118626B/fi not_active IP Right Cessation
-
2000
- 2000-12-27 US US09/749,152 patent/US20010026807A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2986217B2 (ja) | 1999-12-06 |
AU688060B2 (en) | 1998-03-05 |
NO965436L (no) | 1996-12-18 |
US6228396B1 (en) | 2001-05-08 |
US20010026807A1 (en) | 2001-10-04 |
CA2193481A1 (en) | 1995-12-28 |
FI118626B (fi) | 2008-01-31 |
DK0810857T3 (da) | 2001-10-08 |
ATE204751T1 (de) | 2001-09-15 |
AU2746095A (en) | 1996-01-15 |
ES2162922T3 (es) | 2002-01-16 |
EP0810857A1 (en) | 1997-12-10 |
JPH09510478A (ja) | 1997-10-21 |
NO315686B1 (no) | 2003-10-13 |
FI965154A0 (fi) | 1996-12-20 |
PT810857E (pt) | 2001-12-28 |
GB9412394D0 (en) | 1994-08-10 |
WO1995035100A1 (en) | 1995-12-28 |
EP0810857B1 (en) | 2001-08-29 |
DE69522475T2 (de) | 2002-05-08 |
CA2193481C (en) | 2001-03-20 |
NO965436D0 (no) | 1996-12-18 |
DE69522475D1 (de) | 2001-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI965154A (fi) | Lääkkeen paksusuoleen kuljettava koostumus | |
PT1117386E (pt) | Administracao enterica e colonica utilizando capsulas de hpmc | |
NO923590D0 (no) | Doseringsform for avgivelse av medikament til tarmen | |
NO993195L (no) | Blanding for administrasjon av medikamenter | |
ES2104522T3 (es) | Nuevo sistema de administracion de medicamento. | |
ATE81287T1 (de) | Am zielorgan wirkendes enterales abgabesystem. | |
NO973014L (no) | Fyllmateriale for farmasöytisk myk gelatin doseringsform | |
GB9814215D0 (en) | Anti-inflammatory pharmaceutical formulations | |
FI950301A (fi) | Silloitettu polyhydroksyylimateriaali entsymaattisesti kontrolloitua lääkkeen vapauttamista varten | |
FR2735132B1 (fr) | Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant | |
AU668767B2 (en) | Oral medicament form | |
IL113930A (en) | Drug administration form for the controlled release controlled release of active substances in the gastrointestinal tract having a delayed pylorus passage | |
RU96102209A (ru) | Лекарственное средство | |
GB2303550A (en) | Colonic drug delivery composition | |
RU96102195A (ru) | Лекарственное средство |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer of assignment of patent |
Owner name: ARCHIMEDES DEVELOPMENT LIMITED Free format text: ARCHIMEDES DEVELOPMENT LIMITED |
|
FG | Patent granted |
Ref document number: 118626 Country of ref document: FI |
|
MA | Patent expired |